# US 2015/0147785 A1 · 5' protection dependent amplification

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0147785 A1
- Document ID: US20150147785A1
- Status: Published application
- Kind: A1
- Application number: 14/414,104
- Filed: 2013-07-10
- Published: 2015-05-28
- Earliest claimed: 2012-07-10
- Assignees: Lexogen GmbH
- Applicants: Lexogen GmbH
- Inventors: Alexander Seitz; Irmlind Gabler; Lukas Paul
- Web page: https://patentgrep.com/patent/US20150147785A1

## CPC

- C12N 15/1096: {cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR}
- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C12Q 1/6844: Nucleic acid amplification reactions
- C12Q 1/6858: Allele-specific amplification
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention relates to methods for generating a labelled nucleic acid from an RNA comprising a 5′ protecting group, said method comprises the steps of obtaining a mixture of template strands of nucleic acids, said mixture comprising said RNA and further potentially other nucleic acids without a 5′ protecting group, annealing at least one oligonucleotide primer to the template strand of said RNA and potentially other nucleic acids, and template sequence dependent extending said primer, thereby obtaining a complementary nucleic acid strand annealed to its template strand, or providing the RNA in duplex with a complementary nucleic acid strand annealed to its template strand, and optionally modifying the extension product of said nucleic acids without 5′ protecting group either on the 5′ end of the template strand or on the 3′ end of the complementary strand, or both, and labelling a complementary nucleic acid of a double stranded nucleic acid not modified, wherein therefore the labelled nucleic acid did have a 5′ protecting group on the RNA template strand, said 5′ protecting group being optionally removed after modification, and/or labelling a complementary nucleic acid of a double strand dependent on the presence of the 5′ protecting group on the complementary nucleic acids template RNA strand by double strand dependent ligation, thereby specifically generating a labelled nucleic acid complementary to an RNA at least originally comprising a 5′ protecting group.

## Claims

### Claim 1

A method for generating a labelled nucleic acid from an RNA comprising a 5′ protecting group, preferably said protecting group being a 5′ cap or a 5′ polyphosphate, said method comprises the steps of:
a) obtaining a mixture of template strands of nucleic acids, said mixture comprising said RNA and further potentially other nucleic acids without a 5′ protecting group,
b1) annealing at least one oligonucleotide primer to the template strand of said RNA and potentially other nucleic acids, and template sequence dependent extending said primer, thereby obtaining a complementary nucleic acid strand annealed to its template strand, or
b2) providing the RNA in duplex with a complementary nucleic acid strand annealed to its template strand, and
c) optionally modifying the extension product of said nucleic acids without 5′ protecting group either on the 5′ end of the template strand or on the 3′ end of the complementary strand, or both, and
d1) labelling a complementary nucleic acid of a double stranded nucleic acid not modified in step c), wherein therefore the labelled nucleic acid did have a 5′ protecting group on the RNA template strand in step c), said 5′ protecting group being optionally removed after performing step c), and/or d2) labelling a complementary nucleic acid of a double strand dependent on the presence of the 5′ protecting group on the complementary nucleic acids template RNA strand by double strand dependent ligation, thereby specifically generating a labelled nucleic acid complementary to an RNA at least originally comprising a 5′ protecting group.

### Claim 2 (depends on 1)

The method of claim 1, wherein said labelling comprises ligating a nucleic acid sequence tag to said double stranded nucleic acid not modified in step c), preferably wherein said nucleic acid sequence tag is at least partially double stranded, in particular preferred at the ligation end.

### Claim 3 (depends on 1)

The method of claim 1, wherein said modification prevents labelling of said modified double strand.

### Claim 4 (depends on 1)

The method of claim 1, wherein said modification in step c) is selected from i) 5′-3′ exonuclease digestion of uncapped nucleic acids; ii) ligating the 5′ end of the template strand to the 3′ end of the complementary strand; iii) adding a nucleic acid sequence tag lacking said label for the unmodified double stranded nucleic acids; or iv) removing 5′ terminal phosphates on the template strand, preferably by phosphatase, especially preferred while the RNA still contains the 5′ protecting group and is thereby protected from 5′ dephosphorylation.

### Claim 5 (depends on 1)

The method of claim 1, wherein the complementary nucleic acid of an unmodified double stranded nucleic acids is labelled on the 3′ end, preferably wherein the 3′ terminal nucleic acid of the complementary strand is annealed to the template strand with the 5′ terminal nucleotide or the protecting group, preferably a 5′ cap nucleotide, within 0 or 1 nucleotides of said 5′ terminal nucleotide, especially in the case of a 5′ polyphosphate, or the 5′ protecting group, especially in the case of a 5′ cap.

### Claim 6 (depends on 1)

The method of claim 1, wherein said labelling is specific for double strands, preferably double strands with blunt ends or ends with at most 1 nucleotide overhangs.

### Claim 7 (depends on 1)

The method of claim 1, wherein said labeling is specific for doubles strands where the RNA strand comprises a 5′ cap or a 5′ polyphosphate, preferably a 5′ triphosphate, especially preferred wherein said 5′ cap or 5′ polyphosphate is an overhang at the RNA strand 5′ end.

### Claim 8 (depends on 7)

The method of claim 7, wherein in step d2) a label, being a double stranded adapter nucleic acid provided with a 5′ nucleotide overhang on a linker strand, is ligated to said complementary nucleic acid, preferably using a double strand specific ligase.

### Claim 9 (depends on 8)

The method of claim 8, wherein the 5′ nucleotide overhang of the linker strand in the adapter consists of a single nucleotide, preferably a C or a T.

### Claim 10 (depends on 1)

The method of claim 1 further comprising the step e) or enriching, selecting, isolating or purifying nucleic acids with the label, preferably purifying through solid phase binding, or wherein the labelled nucleic acid is amplified through template dependent nucleotide polymerization with the complementary nucleic acid being the template.

### Claim 11 (depends on 1)

The method of claim 1, wherein in step b1) a reverse transcriptase enzyme is used that has inhibited terminal transferase activity or conditions are used that cause a reduction in terminal transferase activity as compared to a non-modified reverse transcriptase at at least 3 mM Mg2+ with abundant dNTPs.

### Claim 12 (depends on 1)

The method of claim 1, wherein a potentially present 3′ overhang on the complementary nucleic acid strand is digested prior to step d1) or d2).

### Claim 13 (depends on 1)

The method of claim 1, wherein in step b1) a reverse transcriptase enzyme that is modified is used, wherein said modification of the enzyme reduces or inhibits the RNAse H activity of the reverse transcriptase enzyme.

### Claim 14 (depends on 1)

The method of claim 1, wherein the oligonucleotide primer is resistant to 5′-3′ exonuclease digestion or has a 5′ overhang, wherein preferably a nucleic acid sequence tag is used as label and said nucleic acid sequence tag is protected from nuclease digestion.

### Claim 15 (depends on 1)

The method of claim 1, wherein on the nucleic acid either a 5′ OH is phosphorylated or a 5′ phosphate is dephosphorylated, preferably when a 5′ phosphate dependent or 5′ OH dependent, respectively, 5′-3′ exonuclease is used for modification in step c).

### Claim 16 (depends on 1)

The method of claim 1, wherein step c) is 5′-3′ exonuclease modification in the presence of a crowding agent.

### Claim 17 (depends on 1)

The method of claim 1, wherein the label comprises a fluorescent molecule, preferably wherein the label is a fluorescent nucleic acid sequence tag, or wherein the label provides protection from 3′-5′ exonucleolytic digestion.

### Claim 18 (depends on 1)

The method of claim 1, wherein the label is immobilized on a solid phase.
